Professional Documents
Culture Documents
PART 1 Growth
Sales Growth: NEGATIVE
Revenues have and are expected to continue to fall by an average of
Returns: DECREASING 2.54% per year through 2018. The overall decrease in Revenue from
2012 to 2018 is 16.69%. Revenues fell by 3.70% in 2015 and are
forecasted to fall by 2013% in 2016 and 2.57% in 2017 and 2018.
Revenues will continue to fall as soda consumption continues to
decline. Coca-Cola is facing issues concerning some of its ingredients,
such as aspartame, that have been linked to cancer and other ailments.
This bad publicity and continual decline in new customers will continue
to cause revenues to shrink.
I chose Dr. Pepper Snapple Group Inc. and Anheuser-Busch InBev SA as competitors with my firm. Dr.
Pepper is more of a direct competitor with many of the same products under a different name as Coca-
Cola. I chose Anheuser-Busch because it competes in the market of beverage sales along with these two
companies. I considered PepsiCo, but I felt that it was too diversified of a company overall to be compared
with just a beverage company. I felt AB (Anheuser-Busch) was a good competitor because it is facing
similar decline in sales in the beer industry. From the financial ratios AB appears to be doing very well with
a steady increase in ROA and very strong upward trend in EPS. This is very good, especially when compared
to Coca Colas data. Dr. Pepper also appears to be faring pretty well when compared to Coca-Cola with a
strong, steady ROS and an increasing ROE.
KO FINANCIAL RATIOS
RETURN ON SALES 24.59% 24.50% 20.27% 21.68%
RETURN ON ASSETS 10.54% 9.58% 7.74% 8.18%
RETURN ON EQUITY 27.39% 25.80% 23.31% 28.59%
EPS $ 2.00 $ 1.94 $ 1.62 $ 1.69
STOCK PRICE
*Article links are highlighted in yellow on the Sources section of the Excel Spreadsheet